
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CASE REPORT article
Front. Pediatr.
Sec. Pediatric Endocrinology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1558179
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Pseudohypoaldosteronism (PHA) type 1 is a rare disease characterized by an end organ unresponsiveness to mineralocorticoids, which results in salt loss from the kidney and impaired potassium and hydrogen secretion. It is subdivided into two main types: renal PHA and systemic PHA that varies in presentation, and severity Case report: Our patient was presented at the age of 1 month with fever and vomiting, electrolyte disturbances, hyponatremia, hyperkalemia and metabolic acidosis. Diagnosed with PHA type 1 caused by a mutation of SCNN1A, later on, she had persistent elevation of liver enzymes for which she was diagnosed with autoimmune hepatitis. She initially was treated with sodium supplements, sodium bicarbonate, and ion exchange resin (calcium polystyrene sulfonate), then subsequently prednisolone and azathioprine were added.We report a unique clinical presentation involving a patient who was diagnosed at the age of 1 month with PHA type 1 caused by a mutation of SCNN1A, and then she was diagnosed with autoimmune hepatitis. The coexistence of these two conditions could highlights a potential shared pathological pathway. Further research into the genetic and immunological links between these rare disorders is warranted
Keywords: autoimmune hepatitis1, Pseudohypoaldosteronism type 12, salt loss3, electrolyte disturbances4, Aldosterone5
Received: 09 Jan 2025; Accepted: 26 Mar 2025.
Copyright: © 2025 Al-Thiabat, khalid, Abdel Razzaq, Barham, Algharaibeh, Alsheyyab and Altamimi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hanan Al-Thiabat, Department of Pediatrics and Neonatology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.